Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2022

31.10.2021 | Original Article

Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature

verfasst von: Antonio Marzollo, Francesca Conti, Linda Rossini, Beatrice Rivalta, Lucia Leonardi, Caterina Tretti, Francesca Tosato, Maria Chiriaco, Giorgiana Madalina Ursu, Cristina Tea Natalucci, Maddalena Martella, Alessandro Borghesi, Cecilia Mancini, Andrea Ciolfi, Gigliola di Matteo, Marco Tartaglia, Caterina Cancrini, Andrea Dotta, Alessandra Biffi, Andrea Finocchi, Silvia Bresolin

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Chronic granulomatous disease (CGD) is a rare inborn error of immunity (IEI), characterized by a deficient phagocyte killing due to the inability of NADPH oxidase to produce reactive oxygen species in the phagosome. Patients with CGD suffer from severe and recurrent infections and chronic inflammatory disorders. Onset of CGD has been rarely reported in neonates and only as single case reports or small case series. We report here the cases of three newborns from two different kindreds, presenting with novel infectious and inflammatory phenotypes associated with CGD. A girl with CYBA deficiency presented with necrotizing pneumonia, requiring a prolonged antibiotic treatment and resulting in fibrotic pulmonary changes. From the second kindred, the first of two brothers developed a fatal Burkholderia multivorans sepsis and died at 24 days of life. His younger brother had a diagnosis of CYBB deficiency and presented with Macrophage Activation Syndrome/Hemophagocytic Lympho-Histiocytosis (MAS/HLH) without any infection, that could be controlled with steroids. We further report the findings of a review of the literature and show that the spectrum of microorganisms causing infections in neonates with CGD is similar to that of older patients, but the clinical manifestations are more diverse, especially those related to the inflammatory syndromes. Our findings extend the spectrum of the clinical presentation of CGD to include unusual neonatal phenotypes. The recognition of the very early, potentially life-threatening manifestations of CGD is crucial for a prompt diagnosis, improvement of survival and reduction of the risk of long-term sequelae.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Thomas DC, Charbonnier LM, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, et al. EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019;143:782-785.e1.PubMed Thomas DC, Charbonnier LM, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, et al. EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019;143:782-785.e1.PubMed
3.
Zurück zum Zitat Prince BT, Thielen BK, Williams KW, Kellner ES, Arnold DE, Cosme-Blanco W, et al. Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease. Pediatr Heal Med Ther [Internet]. 2020;11:257–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32801991 Prince BT, Thielen BK, Williams KW, Kellner ES, Arnold DE, Cosme-Blanco W, et al. Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease. Pediatr Heal Med Ther [Internet]. 2020;11:257–68. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​32801991
5.
Zurück zum Zitat Magnani A, Mahlaoui N. Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease. Pediatr Drugs Springer International Publishing. 2016;18:335–45. Magnani A, Mahlaoui N. Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease. Pediatr Drugs Springer International Publishing. 2016;18:335–45.
6.
Zurück zum Zitat Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol. 2016;27:242–53.PubMed Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol. 2016;27:242–53.PubMed
7.
Zurück zum Zitat Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176–83.PubMed Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176–83.PubMed
8.
Zurück zum Zitat Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. J Allergy Clin Immunol. 2016;138(241):248.e3. Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. J Allergy Clin Immunol. 2016;138(241):248.e3.
9.
10.
Zurück zum Zitat Laskey HL, Gopal L, Gallin JI, Holland SM, Heller T. Twenty-Year Follow-Up of Esophageal Involvement in Chronic Granulomatous Disease. Am J Gastroenterol. 2009;104:2368–70.PubMedPubMedCentral Laskey HL, Gopal L, Gallin JI, Holland SM, Heller T. Twenty-Year Follow-Up of Esophageal Involvement in Chronic Granulomatous Disease. Am J Gastroenterol. 2009;104:2368–70.PubMedPubMedCentral
11.
Zurück zum Zitat Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114(462):8. Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114(462):8.
12.
Zurück zum Zitat Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28:67–72. Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28:67–72.
14.
Zurück zum Zitat Álvarez-Cardona A, Rodríguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous Immunoglobulin Treatment for Macrophage Activation Syndrome Complicating Chronic Granulomatous Disease. J Clin Immunol. 2012;32:207–11.PubMed Álvarez-Cardona A, Rodríguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous Immunoglobulin Treatment for Macrophage Activation Syndrome Complicating Chronic Granulomatous Disease. J Clin Immunol. 2012;32:207–11.PubMed
15.
Zurück zum Zitat Wei A, Ma H, Zhang L, Li Z, Zhang Q, Wang D, et al. Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review. BMC Pediatr BMC Pediatrics. 2020;20:100.PubMed Wei A, Ma H, Zhang L, Li Z, Zhang Q, Wang D, et al. Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review. BMC Pediatr BMC Pediatrics. 2020;20:100.PubMed
16.
Zurück zum Zitat van den Berg JM, van Koppen E, Åhlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: The European experience. PLoS ONE. 2009;4:1–10. van den Berg JM, van Koppen E, Åhlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: The European experience. PLoS ONE. 2009;4:1–10.
17.
Zurück zum Zitat Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study. Clin Immunol. 2008;126:155–64.PubMed Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study. Clin Immunol. 2008;126:155–64.PubMed
18.
Zurück zum Zitat Hasui TSGOPD. Chronic granulomatous disease in Japan: Incidence and natural history. Pediatr Int. 1999;41(589):93. Hasui TSGOPD. Chronic granulomatous disease in Japan: Incidence and natural history. Pediatr Int. 1999;41(589):93.
19.
Zurück zum Zitat Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease douglas. N Engl J Med. 2010;363:2600–10.PubMedPubMedCentral Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease douglas. N Engl J Med. 2010;363:2600–10.PubMedPubMedCentral
20.
Zurück zum Zitat Åhlin A, Boer M, Roos D, Leusen J, Smith C, Sundin U, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84:1386–94.PubMed Åhlin A, Boer M, Roos D, Leusen J, Smith C, Sundin U, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84:1386–94.PubMed
21.
Zurück zum Zitat Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients. Medicine (Baltimore). 2000;79:155–69. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients. Medicine (Baltimore). 2000;79:155–69.
22.
Zurück zum Zitat Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000;137:687–93.PubMed Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000;137:687–93.PubMed
23.
Zurück zum Zitat Marzollo A, Maestrini G, La Starza R, Elia L, Malfona F, Pierini T, et al. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell Acute Lymphoblastic Leukaemia. Am J Hematol. 2020;95(12):E335–8.PubMed Marzollo A, Maestrini G, La Starza R, Elia L, Malfona F, Pierini T, et al. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL/LMO T-cell Acute Lymphoblastic Leukaemia. Am J Hematol. 2020;95(12):E335–8.PubMed
24.
Zurück zum Zitat Motta M, Pannone L, Pantaleoni F, Bocchinfuso G, Radio FC, Cecchetti S, et al. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum. Am J Hum Genet. 2020;107:499–513.PubMedPubMedCentral Motta M, Pannone L, Pantaleoni F, Bocchinfuso G, Radio FC, Cecchetti S, et al. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum. Am J Hum Genet. 2020;107:499–513.PubMedPubMedCentral
25.
Zurück zum Zitat Lin Y-C, Niceta M, Muto V, Vona B, Pagnamenta AT, Maroofian R, et al. SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling. Am J Hum Genet. 2021;108:115–33.PubMed Lin Y-C, Niceta M, Muto V, Vona B, Pagnamenta AT, Maroofian R, et al. SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling. Am J Hum Genet. 2021;108:115–33.PubMed
26.
Zurück zum Zitat Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy- Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinforma. 2013;43:11.10.1-11.10.33. Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy- Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinforma. 2013;43:11.10.1-11.10.33.
27.
Zurück zum Zitat Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.PubMedPubMedCentral Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–60.PubMedPubMedCentral
29.
Zurück zum Zitat Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34:E2393-402.PubMedPubMedCentral Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: a database of human non-synonymous SNVs and their functional predictions and annotations. Hum Mutat. 2013;34:E2393-402.PubMedPubMedCentral
31.
Zurück zum Zitat Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48:1581–6.PubMed Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48:1581–6.PubMed
32.
Zurück zum Zitat Li Q, Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100:267–80.PubMedPubMedCentral Li Q, Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100:267–80.PubMedPubMedCentral
34.
Zurück zum Zitat Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44(291):9. Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44(291):9.
35.
Zurück zum Zitat Ehl S, Astigarraga I, von Bahr GT, Hines M, Horne AC, Ishii E, et al. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6:1508–17.PubMed Ehl S, Astigarraga I, von Bahr GT, Hines M, Horne AC, Ishii E, et al. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6:1508–17.PubMed
36.
Zurück zum Zitat Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, et al. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagnostics. 2010;12(368):76. Hill HR, Augustine NH, Pryor RJ, Reed GH, Bagnato JD, Tebo AE, et al. Rapid genetic analysis of X-linked chronic granulomatous disease by high-resolution melting. J Mol Diagnostics. 2010;12(368):76.
37.
Zurück zum Zitat Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(246):65. Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(246):65.
38.
Zurück zum Zitat Lazarus GM, Neu HC. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr. 1975;86(415):7. Lazarus GM, Neu HC. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr. 1975;86(415):7.
39.
Zurück zum Zitat Davoodi P, Wright SA, Brown EV, Perry JR. Rare diagnosis in a neonate who presents with fever. Clin Pediatr (Phila). 2015;54:91–3. Davoodi P, Wright SA, Brown EV, Perry JR. Rare diagnosis in a neonate who presents with fever. Clin Pediatr (Phila). 2015;54:91–3.
41.
Zurück zum Zitat Shigemura T, Nakazawa Y, Yoshikawa K, Hirabayashi K, Saito S, Kobayashi N, et al. Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis. Transfusion. 2014;54(516):21. Shigemura T, Nakazawa Y, Yoshikawa K, Hirabayashi K, Saito S, Kobayashi N, et al. Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis. Transfusion. 2014;54(516):21.
42.
Zurück zum Zitat Gonzalez LA, Kiff JE, Umetsu DT. A three-week-old infant with invasive pulmonary aspergillosis. Ann Allergy. 1994;73(392):400. Gonzalez LA, Kiff JE, Umetsu DT. A three-week-old infant with invasive pulmonary aspergillosis. Ann Allergy. 1994;73(392):400.
44.
Zurück zum Zitat Herman TE, Siegel MJ. Chronic granulomatous disease of childhood: neonatal serratia, hepatic abscesses, and pulmonary aspergillosis. J Perinatol. 2002;22(255):6. Herman TE, Siegel MJ. Chronic granulomatous disease of childhood: neonatal serratia, hepatic abscesses, and pulmonary aspergillosis. J Perinatol. 2002;22(255):6.
45.
Zurück zum Zitat Salfa I, Cantarutti N, Angelino G, Di Matteo G, Capo V, Farinelli G, et al. Serratia marcescens osteomyelitis in a newborn with chronic granulomatous disease. Pediatr Infect Dis J. 2013;32:926.PubMed Salfa I, Cantarutti N, Angelino G, Di Matteo G, Capo V, Farinelli G, et al. Serratia marcescens osteomyelitis in a newborn with chronic granulomatous disease. Pediatr Infect Dis J. 2013;32:926.PubMed
46.
Zurück zum Zitat McElroy JA, Monahan SH, Williams JV. A female neonate presenting with fever and rash. Clin Pediatr (Phila). 2011;50(779):81. McElroy JA, Monahan SH, Williams JV. A female neonate presenting with fever and rash. Clin Pediatr (Phila). 2011;50(779):81.
49.
Zurück zum Zitat Johnston HC, Shigeoka AO, Hurley DC, Pysher TJ. Nocardia pneumonia in a neonate with chronic granulomatous disease. Pediatr Infect Dis J. 1989;8(526):8. Johnston HC, Shigeoka AO, Hurley DC, Pysher TJ. Nocardia pneumonia in a neonate with chronic granulomatous disease. Pediatr Infect Dis J. 1989;8(526):8.
51.
Zurück zum Zitat Afrough R, Mohseni SS, Sagheb S. An Uncommon Feature of Chronic Granulomatous Disease in a Neonate. Case Rep Infect Dis. 2016;2016:1–4. Afrough R, Mohseni SS, Sagheb S. An Uncommon Feature of Chronic Granulomatous Disease in a Neonate. Case Rep Infect Dis. 2016;2016:1–4.
52.
Zurück zum Zitat Narchi H, Gammoh S, Azimi P, Grossman M. Multiple nodular pneumonitis in a three-week-old female infant. Pediatr Infect Dis J. 1999;18:1–6. Narchi H, Gammoh S, Azimi P, Grossman M. Multiple nodular pneumonitis in a three-week-old female infant. Pediatr Infect Dis J. 1999;18:1–6.
53.
Zurück zum Zitat Armanian A-M, Iravani P, Mohammadizadeh M, Rahimi H. Multifocal abscess in a neonate: Neonatal chronic Granulomatous disease. Case report SEAJCRR. 2014;856:67. Armanian A-M, Iravani P, Mohammadizadeh M, Rahimi H. Multifocal abscess in a neonate: Neonatal chronic Granulomatous disease. Case report SEAJCRR. 2014;856:67.
54.
Zurück zum Zitat Gray PEA, Bock V, Ziegler DS, Wargon O. Neonatal Sweet Syndrome: A potential marker of serious systemic illness. Pediatrics. 2012;129(5):e1353-9.PubMed Gray PEA, Bock V, Ziegler DS, Wargon O. Neonatal Sweet Syndrome: A potential marker of serious systemic illness. Pediatrics. 2012;129(5):e1353-9.PubMed
55.
Zurück zum Zitat Labrosse R, Abou-Diab J, Blincoe A, Cros G, Luu TM, Deslandres C, et al. Very early-onset inflammatory manifestations of X-Linked chronic granulomatous disease. Front Immunol. 2017;8:1–7. Labrosse R, Abou-Diab J, Blincoe A, Cros G, Luu TM, Deslandres C, et al. Very early-onset inflammatory manifestations of X-Linked chronic granulomatous disease. Front Immunol. 2017;8:1–7.
56.
Zurück zum Zitat Miladinovic M, Wittekindt B, Fischer S, Gradhand E, Kunzmann S, Zimmermann SY, et al. Case Report: Symptomatic Chronic Granulomatous Disease in the Newborn. Front Immunol. 2021;12:663883.PubMedPubMedCentral Miladinovic M, Wittekindt B, Fischer S, Gradhand E, Kunzmann S, Zimmermann SY, et al. Case Report: Symptomatic Chronic Granulomatous Disease in the Newborn. Front Immunol. 2021;12:663883.PubMedPubMedCentral
58.
Zurück zum Zitat Lee AH, Shannon CP, Amenyogbe N, Bennike TB, Diray-Arce J, Idoko OT, et al. Dynamic molecular changes during the first week of human life follow a robust developmental trajectory. Nat Commun. 2019;10:1092.PubMedPubMedCentral Lee AH, Shannon CP, Amenyogbe N, Bennike TB, Diray-Arce J, Idoko OT, et al. Dynamic molecular changes during the first week of human life follow a robust developmental trajectory. Nat Commun. 2019;10:1092.PubMedPubMedCentral
61.
Zurück zum Zitat Bertulli C, Marzollo A, Doria M, Di Cesare S, La Scola C, Mencarelli F, et al. Expanding Phenotype of Schimke Immuno-Osseous Dysplasia: Congenital Anomalies of the Kidneys and of the Urinary Tract and Alteration of NK Cells. Int J Mol Sci. 2020;21:8604.PubMedCentral Bertulli C, Marzollo A, Doria M, Di Cesare S, La Scola C, Mencarelli F, et al. Expanding Phenotype of Schimke Immuno-Osseous Dysplasia: Congenital Anomalies of the Kidneys and of the Urinary Tract and Alteration of NK Cells. Int J Mol Sci. 2020;21:8604.PubMedCentral
63.
Zurück zum Zitat Michev A, Borghesi A, Tretti C, Martella M, Di Comite A, Biffi A, et al. Neonatal-Onset Familial Mediterranean Fever in an Infant with Human Parainfluenza Virus-4 Infection. Neonatology. 2021;118(3):359–63.PubMed Michev A, Borghesi A, Tretti C, Martella M, Di Comite A, Biffi A, et al. Neonatal-Onset Familial Mediterranean Fever in an Infant with Human Parainfluenza Virus-4 Infection. Neonatology. 2021;118(3):359–63.PubMed
67.
Zurück zum Zitat Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J. 2008;31(6):1285–91. Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J. 2008;31(6):1285–91.
68.
Zurück zum Zitat Hoppe PA, Holzhauer S, Lala B, Bührer C, Gratopp A, Hanitsch LG, et al. Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children. Med (United States). 2019;98:1–7. Hoppe PA, Holzhauer S, Lala B, Bührer C, Gratopp A, Hanitsch LG, et al. Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children. Med (United States). 2019;98:1–7.
69.
Zurück zum Zitat Viel-Thériault I, Saban J, Lewis A, Bariciak E, Grynspan D. A Case of Fulminant Bacillus cereus Lung Necrosis in a Preterm Neonate. Pediatr Dev Pathol. 2019;22:461–4.PubMed Viel-Thériault I, Saban J, Lewis A, Bariciak E, Grynspan D. A Case of Fulminant Bacillus cereus Lung Necrosis in a Preterm Neonate. Pediatr Dev Pathol. 2019;22:461–4.PubMed
70.
Zurück zum Zitat Valentine G, Thomas TA, Nguyen T, Lai YC. Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: A case report. Pediatrics. 2014;134:e1727–30.PubMed Valentine G, Thomas TA, Nguyen T, Lai YC. Chronic granulomatous disease presenting as hemophagocytic lymphohistiocytosis: A case report. Pediatrics. 2014;134:e1727–30.PubMed
71.
Zurück zum Zitat Parekh C, Hofstra T, Church JA, Coates TD. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease. Pediatr Blood Cancer. 2011;56:460–2.PubMed Parekh C, Hofstra T, Church JA, Coates TD. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease. Pediatr Blood Cancer. 2011;56:460–2.PubMed
72.
Zurück zum Zitat Urriola N, Williams A, Keat K. Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to Burkholderia cepacia complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: ‘cepacia syndrome’ revisited. BMJ Case Rep. 2019;12:e230434.PubMedPubMedCentral Urriola N, Williams A, Keat K. Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to Burkholderia cepacia complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: ‘cepacia syndrome’ revisited. BMJ Case Rep. 2019;12:e230434.PubMedPubMedCentral
73.
Zurück zum Zitat van Montfrans JM, Rudd E, van de Corput L, Henter J-I, Nikkels P, Wulffraat N, et al. Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant. Pediatr Blood Cancer. 2009;52:527–9.PubMed van Montfrans JM, Rudd E, van de Corput L, Henter J-I, Nikkels P, Wulffraat N, et al. Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant. Pediatr Blood Cancer. 2009;52:527–9.PubMed
74.
Zurück zum Zitat Hisano M, Sugawara K, Tatsuzawa O, Kitagawa M, Murashima A, Yamaguchi K. Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease. J Med Microbiol. 2007;56:702–5.PubMed Hisano M, Sugawara K, Tatsuzawa O, Kitagawa M, Murashima A, Yamaguchi K. Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease. J Med Microbiol. 2007;56:702–5.PubMed
75.
Zurück zum Zitat Akagi K, Kawai T, Watanabe N, Yokoyama M, Arai K, Harayama S, et al. A Case of Macrophage Activation Syndrome Developing in a Patient With Chronic Granulomatous Disease-associated Colitis. J Pediatr Hematol Oncol. 2014;36:e169–72.PubMed Akagi K, Kawai T, Watanabe N, Yokoyama M, Arai K, Harayama S, et al. A Case of Macrophage Activation Syndrome Developing in a Patient With Chronic Granulomatous Disease-associated Colitis. J Pediatr Hematol Oncol. 2014;36:e169–72.PubMed
76.
Zurück zum Zitat Sirinavin S, Techasaensiri C, Pakakasama S, Vorachit M, Pornkul R, Wacharasin R. Hemophagocytic Syndrome and Burkholderia cepacia Splenic Microabscesses in a Child With Chronic Granulomatous Disease. Pediatr Infect Dis J. 2004;23:882–4.PubMed Sirinavin S, Techasaensiri C, Pakakasama S, Vorachit M, Pornkul R, Wacharasin R. Hemophagocytic Syndrome and Burkholderia cepacia Splenic Microabscesses in a Child With Chronic Granulomatous Disease. Pediatr Infect Dis J. 2004;23:882–4.PubMed
77.
Zurück zum Zitat Maignan M, Verdant C, Bouvet GF, Van Spall M, Berthiaume Y. Undiagnosed Chronic Granulomatous Disease, Burkholderia cepacia complex Pneumonia, and Acquired Hemophagocytic Lymphohistiocytosis: A Deadly Association. Case Rep Pulmonol. 2013;2013:1–5. Maignan M, Verdant C, Bouvet GF, Van Spall M, Berthiaume Y. Undiagnosed Chronic Granulomatous Disease, Burkholderia cepacia complex Pneumonia, and Acquired Hemophagocytic Lymphohistiocytosis: A Deadly Association. Case Rep Pulmonol. 2013;2013:1–5.
78.
Zurück zum Zitat Heeg M, Ammann S, Klemann C, Panning M, Falcone V, Hengel H, et al. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease. Pediatr Blood Cancer. 2018;65:e27344.PubMedPubMedCentral Heeg M, Ammann S, Klemann C, Panning M, Falcone V, Hengel H, et al. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease. Pediatr Blood Cancer. 2018;65:e27344.PubMedPubMedCentral
80.
Zurück zum Zitat Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22:561–6.PubMedPubMedCentral Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22:561–6.PubMedPubMedCentral
81.
Zurück zum Zitat Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587–90.PubMed Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587–90.PubMed
82.
Zurück zum Zitat Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat. Arthritis Rheumatol. 2016;68:566–76.PubMed Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborat. Arthritis Rheumatol. 2016;68:566–76.PubMed
84.
Zurück zum Zitat Walther MM, Malech H, Berman A, Choyke P, Venzon DJ, Linehan WM, et al. The urological manifestations of chronic granulomatous disease. J Urol. 1992;147(1314):8. Walther MM, Malech H, Berman A, Choyke P, Venzon DJ, Linehan WM, et al. The urological manifestations of chronic granulomatous disease. J Urol. 1992;147(1314):8.
85.
Zurück zum Zitat Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34(58):67. Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34(58):67.
86.
Zurück zum Zitat Hou L, Niu W-T, Ji H-Y, Hu X-F, Fang F, Ying Y-Q. Serum Biomarkers for Early Diagnosis of Chinese X-CGD Children: Case Reports and a Literature Review. Curr Med Sci. 2019;39(343):8. Hou L, Niu W-T, Ji H-Y, Hu X-F, Fang F, Ying Y-Q. Serum Biomarkers for Early Diagnosis of Chinese X-CGD Children: Case Reports and a Literature Review. Curr Med Sci. 2019;39(343):8.
88.
Zurück zum Zitat Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168(149):55. Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009;168(149):55.
89.
Zurück zum Zitat Boonyawat B, Suksawat Y, Pacharn P, Suwanpakdee P, Traivaree C. X-Linked Chronic Granulomatous Disease: Initial Presentation with Intracranial Hemorrhage from Vitamin K Deficiency in Infant. Case Rep Pediatr. 2018;2018:7041204.PubMedPubMedCentral Boonyawat B, Suksawat Y, Pacharn P, Suwanpakdee P, Traivaree C. X-Linked Chronic Granulomatous Disease: Initial Presentation with Intracranial Hemorrhage from Vitamin K Deficiency in Infant. Case Rep Pediatr. 2018;2018:7041204.PubMedPubMedCentral
Metadaten
Titel
Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature
verfasst von
Antonio Marzollo
Francesca Conti
Linda Rossini
Beatrice Rivalta
Lucia Leonardi
Caterina Tretti
Francesca Tosato
Maria Chiriaco
Giorgiana Madalina Ursu
Cristina Tea Natalucci
Maddalena Martella
Alessandro Borghesi
Cecilia Mancini
Andrea Ciolfi
Gigliola di Matteo
Marco Tartaglia
Caterina Cancrini
Andrea Dotta
Alessandra Biffi
Andrea Finocchi
Silvia Bresolin
Publikationsdatum
31.10.2021
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2022
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01159-4

Weitere Artikel der Ausgabe 2/2022

Journal of Clinical Immunology 2/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.